NCT01369498 2020-07-01Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia MyelofibrosisGilead SciencesPhase 2 Completed54 enrolled 16 charts